The Enterprise Value as of December 2025 (TTM) for Coeptis Therapeutics, Inc. (COEP) is 52.89M

According to Coeptis Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 52.89M. This represents a change of 46.60% compared to the average of 36.08M of the last 4 quarters.

Coeptis Therapeutics, Inc. (COEP) Historical Enterprise Value (quarterly & annually)

How has COEP Enterprise Value performed in the past?

The mean historical Enterprise Value of Coeptis Therapeutics, Inc. over the last ten years is 829.65M. The current 52.89M Enterprise Value has changed 537.48% with respect to the historical average. Over the past ten years (40 quarters), COEP's Enterprise Value was at its highest in in the March 2022 quarter at 4.13B. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Coeptis Therapeutics, Inc. (COEP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Coeptis Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Coeptis Therapeutics, Inc. (COEP) Average Enterprise Value

How has COEP Enterprise Value performed in the past?

The current Enterprise Value of Coeptis Therapeutics, Inc. (COEP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Coeptis Therapeutics, Inc. (COEP) Enterprise Value vs. Peers

How is COEP’s Enterprise Value compared to its peers?

Coeptis Therapeutics, Inc.’s Enterprise Value is greater than Equillium, Inc. (-1382527.00), greater than Century Therapeutics, Inc. (39.85M), greater than Cue Biopharma, Inc. (23.68M), greater than NRx Pharmaceuticals, Inc. (35.34M), less than Karyopharm Therapeutics Inc. (112.81M), less than Outlook Therapeutics, Inc. (117.30M), greater than Medicus Pharma Ltd. Common Stock (33.87M), greater than OS Therapies Incorporated (-1812535881.00), less than Senti Biosciences, Inc. (76.24M), greater than Telomir Pharmaceuticals, Inc. Common Stock (39.43M),

Build a custom stock screener for Coeptis Therapeutics, Inc. (COEP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Coeptis Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Coeptis Therapeutics, Inc. (COEP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Coeptis Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.